Form 8-K - Current report:
SEC Accession No. 0001628280-24-021241
Filing Date
2024-05-08
Accepted
2024-05-07 18:08:43
Documents
16
Period of Report
2024-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K natr-20240501.htm   iXBRL 8-K 46981
2 EX-99.1 natrq12024earningsrelease.htm EX-99.1 227695
6 GRAPHIC image.jpg GRAPHIC 8667
7 GRAPHIC natr-20240501_g1.jpg GRAPHIC 117340
  Complete submission text file 0001628280-24-021241.txt   719303

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT natr-20240501.xsd EX-101.SCH 1913
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT natr-20240501_lab.xml EX-101.LAB 20770
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT natr-20240501_pre.xml EX-101.PRE 11993
19 EXTRACTED XBRL INSTANCE DOCUMENT natr-20240501_htm.xml XML 2645
Mailing Address 2901 WEST BLUEGRASS BLVD. SUITE 100 LEHI UT 84043
Business Address 2901 WEST BLUEGRASS BLVD. SUITE 100 LEHI UT 84043 (801) 341-7900
NATURES SUNSHINE PRODUCTS INC (Filer) CIK: 0000275053 (see all company filings)

EIN.: 870327982 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34483 | Film No.: 24923548
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)